Literature DB >> 26220829

Evaluating the Validity of Caffeine Use Disorder.

Alan J Budney1, Dustin C Lee, Laura M Juliano.   

Abstract

Caffeine use disorder is included in the conditions for further study section of the DSM-5. Caffeine's profile of neurobiological, behavioral, and clinical effects is similar to other common substances that humans use recreationally. Extant data suggest that a clinically meaningful addictive disorder develops in some regular caffeine users, but this literature is incomplete and not yet sufficient to determine if and how best to define and treat caffeine use disorder. An overview of the literature relevant to determining the clinical importance of problematic caffeine use is followed by discussion of potential concerns and benefits associated with its classification as a mental disorder. Concerns about overdiagnosis and trivialization of other psychiatric syndromes are weighed against the public health benefits of increased awareness and development of interventions targeting problematic caffeine use. This discussion includes consideration of alternative diagnostic approaches, improvement of assessment practices, and the need for additional clinical and epidemiological research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26220829     DOI: 10.1007/s11920-015-0611-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  32 in total

Review 1.  Caffeine Use Disorder: A Comprehensive Review and Research Agenda.

Authors:  Steven E Meredith; Laura M Juliano; John R Hughes; Roland R Griffiths
Journal:  J Caffeine Res       Date:  2013-09

2.  Physical dependence increases the relative reinforcing effects of caffeine versus placebo.

Authors:  B E Garrett; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

3.  A survey of physician advice about caffeine.

Authors:  J R Hughes; G Amori; D K Hatsukami
Journal:  J Subst Abuse       Date:  1988

4.  Reinforcing and subjective effects of caffeine in normal human volunteers.

Authors:  K N Stern; L D Chait; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  Should criteria for drug dependence differ across drugs?

Authors:  John R Hughes
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

6.  DSM-5, psychiatric epidemiology and the false positives problem.

Authors:  J C Wakefield
Journal:  Epidemiol Psychiatr Sci       Date:  2015-02-13       Impact factor: 6.892

7.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

8.  Caffeine's implications for women's health and survey of obstetrician-gynecologists' caffeine knowledge and assessment practices.

Authors:  Britta L Anderson; Laura M Juliano; Jay Schulkin
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

Review 9.  Caffeine and cognitive performance: persistent methodological challenges in caffeine research.

Authors:  Jack E James
Journal:  Pharmacol Biochem Behav       Date:  2014-06-02       Impact factor: 3.533

10.  Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens.

Authors:  Marcello Solinas; Sergi Ferré; Zhi-Bing You; Marzena Karcz-Kubicha; Patrizia Popoli; Steven R Goldberg
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  6 in total

Review 1.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

2.  Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use Disorders.

Authors:  Elizabeth Harstad; Georgios Sideridis; Lon Sherritt; Lydia A Shrier; Rosemary Ziemnik; Sharon Levy
Journal:  J Caffeine Res       Date:  2016-12-01

Review 3.  Craving espresso: the dialetics in classifying caffeine as an abuse drug.

Authors:  Max Kenedy Felix Dos Santos; Elaine C Gavioli; Lorena Santa Rosa; Vanessa de Paula Soares-Rachetti; Bruno Lobão-Soares
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-18       Impact factor: 3.000

4.  A brief manualized treatment for problematic caffeine use: A randomized control trial.

Authors:  Daniel P Evatt; Laura M Juliano; Roland R Griffiths
Journal:  J Consult Clin Psychol       Date:  2015-10-26

Review 5.  The Safety of Ingested Caffeine: A Comprehensive Review.

Authors:  Jennifer L Temple; Christophe Bernard; Steven E Lipshultz; Jason D Czachor; Joslyn A Westphal; Miriam A Mestre
Journal:  Front Psychiatry       Date:  2017-05-26       Impact factor: 4.157

6.  Validation of the Turkish Version of the Caffeine Use Disorder Questionnaire in an Adult Population.

Authors:  Seda Kaya; Mahmut Bodur; Merve İlhan Esgin; Funda Pınar Çakıroğlu; Ayşe Özfer Özçelik
Journal:  Int J Ment Health Addict       Date:  2021-11-01       Impact factor: 3.836

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.